A bacterial cell infected with T4 phage rapidly establishes resistance against further infections by the same or closely related T-even-type bacteriophages – a phenomenon called superinfection exclusion. Here we show that one of the T4 early gene products and a periplasmic protein, Spackle, forms a stoichiometric complex with the lysozyme domain of T4 tail spike protein gp5 and potently inhibits its activity. Crystal structure of the Spackle-gp5 lysozyme complex shows that Spackle binds to a horseshoe-shaped basic patch surrounding the oligosaccharide-binding cleft and induces an allosteric conformational change of the active site. In contrast, Spackle does not appreciably inhibit the lysozyme activity of cytoplasmic T4 endolysin responsible for cell lysis to release progeny phage particles at the final step of the lytic cycle. Our work reveals a unique mode of inhibition for lysozymes, a widespread class of enzymes in biology, and provides a mechanistic understanding of the T4 bacteriophage superinfection exclusion.
The lifecycle of bacteriophage T4 starts with the attachment of phage virion to host Escherichia coli surface, which entails reversible binding of the phage’s long tail fibers to bacterial outer membrane protein C (OmpC) or lipopolysaccharide, followed by irreversible adsorption of the short tail fibers to the bacterial surface1,2. The attachment triggers a conformational change of the baseplate at the distal end of the phage tail tube and contraction of tail sheath, revealing a puncturing device for penetration of the bacterial cell envelope and delivery of the viral DNA3,4. The T4 spike protein gp5 (gene product 5) located at the tip of this puncturing device has an internal lysozyme domain and the C-terminal domain that is folded into a trimeric β-helix and functions as a needle to penetrate the bacterial outer membrane3,5,6 (Supplementary Fig. S1). A subsequent release of the β-helix domain from the baseplate activates gp5 lysozyme activity, which degrades peptidoglycan in the bacterial cell wall7. Lastly, the tail tube fuses with a remodeled bacterial inner membrane via a less well-understood mechanism to promote the release of the viral DNA genome into the bacterial cytoplasm8.
One of the T4 early gene products produced immediately following the genome injection is gp61.3, also known as Spackle. Spackle, along with another T4 gene product Imm, confers the infected host E. coli with resistance against secondary phage infections—a phenomenon known as “superinfection exclusion”9,10,11,12. Genetic studies have led to a hypothesis that Spackle achieves superinfection exclusion by inhibiting the gp5 lysozyme activity in the periplasm of infected bacteria and thereby preventing the penetration of the tail tube of incoming phages13,14,15,16,17,18. Our recent studies have shown that the mature, 75-amino acid Spackle protein after proteolytic cleavage of the periplasmic localization signal has a compact α-helical bundle fold with a disulfide bond, consistent with its presumed function in the periplasm19. However, it is currently unknown whether Spackle actually interacts with the tail (gp5) lysozyme or inhibits its glycoside hydrolase activity. Here, we address this question through structural and biochemical studies. Our results show that T4 Spackle forms a stoichiometric complex with the lysozyme domain of gp5 and potently inhibits its enzymatic activity, whereas Spackle does not appreciably inhibit the cytoplasmic T4 lysozyme (endolysin, gpe) responsible for cell lysis at the final step of the phage lytic cycle. Crystal structure of the Spackle–gp5 complex shows that the binding of Spackle induces an allosteric conformational change in the gp5 lysozyme active site and partially blocks its oligosaccharide-binding cleft. Our work reveals a mode of lysozyme inhibition distinct from those used by the bacterial proteinaceous lysozyme inhibitors and provides mechanistic understanding of the T4 bacteriophage superinfection exclusion.
T4 Spackle binds gp5 lysozyme
To test whether the tail lysozyme and Spackle directly interact, we expressed the lysozyme domain of T4 gp5, which spans residues Met174 to Glu342 of full-length gp5. Full-length mature Spackle (Gly23 to Glu97) was also purified as a soluble protein, as reported previously19. When the purified Spackle (9.7 kDa) and the lysozyme domain of gp5 (20.1 kDa, hereinafter referred to as gp5 lysozyme) were individually injected into a Superdex 75 size-exclusion chromatography (SEC) column, either protein alone eluted as single peaks with the apparent masses of 8 and 17 kDa based on elution volume, respectively, which are slightly smaller than their actual monomer molecular masses. On the other hand, when gp5 lysozyme and Spackle were mixed and co-injected into the SEC column, the two proteins co-eluted earlier than either protein alone, suggesting that they formed a stable complex (Fig. 1a). The apparent mass of the complex based on the elution volume of the SEC peak (~23 kDa) and relative band intensities in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for the two proteins co-eluted from the column was consistent with the complex containing a 1:1 molar ratio of gp5 lysozyme and Spackle (Fig. 1b).
Crystal structure of the Spackle–gp5 lysozyme complex
Given that Spackle and gp5 lysozyme form a stable complex in solution, we sought to understand the mechanism of this protein–protein interaction through structural analysis. To that end, we co-crystallized Spackle and gp5 lysozyme and determined the crystal structure of the complex by molecular replacement phasing. Two crystal forms were obtained, in monoclinic and orthorhombic lattice systems, for which the structures were refined to 1.78 and 1.92 Å resolution, respectively. As expected, the crystal structures show a 1:1 Spackle–gp5 lysozyme complex (Fig. 2a–c). The monoclinic crystal contained two Spackle–gp5 lysozyme complexes in the asymmetric unit, whereas the orthorhombic crystal contained one complex in the asymmetric unit. In addition, we observed several 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) molecules bound on the lysozyme surface, including one occupying the oligosaccharide-binding cleft (C-site)20 and another in the peptide-binding groove in the monoclinic crystal structure (Fig. 2a). The protein structures of the three crystallographically independent complexes were essentially identical to each other, with pairwise backbone room mean square deviations within 0.5 Å.
Spackle–gp5 lysozyme interaction
Spackle binds to gp5 lysozyme primarily via three short helices (α1, α4, and α5) located on one side of its flat helical bundle fold. The interface buries a total of 952 Å2 surface area and involves numerous polar contacts (Fig. 2a, c). Spackle engages a highly positively charged horseshoe-shaped surface around the deep substrate-binding cleft, spanning both the N and C-terminal lobes of lysozyme (Fig. 2b, c). The side chains of a number of basic amino acid residues of gp5 lysozyme, namely Arg181, Arg182, Arg187, and Lys189 from the N-terminal lobe and Arg312, Lys321, and Arg326 from the C-terminal lobe, are involved in intermolecular hydrogen bonds or salt bridges with Spackle (Fig. 3). Many main-chain atoms from either protein also make direct contacts at the interface. For instance, the main chains of Trp192 and Leu186 from gp5 lysozyme make bidentate hydrogen bonds with the side chain carboxamide moieties of Gln37 and Asn76 from Spackle, respectively; the main-chain carbonyl groups of Ser32, Met33, Thr34, and Ala35 from Spackle at the C-terminus of α1 helix accept a cluster of hydrogen bonds from gp5 lysozyme (Fig. 3). Although Spackle binds over and partially blocks a distal site (E/F-site)21 in the substrate-binding cleft of lysozyme, it does not block the enzyme active site or interact directly with the catalytic residues (Glu184 and Asp193) (Fig. 2a).
Protein structural changes upon binding
Superposition of Spackle and gp5 lysozyme structures in the complex with their respective unbound state structures shows conformational changes for both proteins upon binding. In the Spackle-bound gp5 lysozyme, compared to its structure in the full-length trimeric (gp27–gp5)3 complex22, both N and C-terminal lobes are rotated away from each other so as to widen the substrate-binding cleft (Fig. 4a). The conformational change displaces the lysozyme catalytic residues (Glu184 and Asp193), both of which are in the N-terminal lobe, with respect to the oligosaccharide-binding sites. The α4 and α5 helices of Spackle are stuck at the mouth of this widened cleft, which could stabilize its forced-open conformation (Fig. 2a, b). In the lysozyme-bound Spackle, compared to its free state19, the short α1 helix is kinked in the middle toward Arg187, Leu188, and Lys189 of gp5 lysozyme, which donate hydrogen bonds to the residues at the C-terminal end of this helix (Fig. 3). This causes the residues N-terminal to the kink, Lys26 to Cys29, to lose their regular α-helical structure (Fig. 4b). Notably, the electron density for Cys29 and Cys81 of Spackle, which were observed to be disulfide-bonded in the unliganded structure, is best accounted for when the model was refined as a mixture of ~60% oxidized (disulfide-bonded) and ~40% reduced (Sγ–Sγ distance of 3.0 Å) species. The partial loss of disulfide linkage may reflect the conformational strain in α1 helix upon lysozyme binding and resulting bond breakage or preferential binding of Spackle in the reduced form during crystallization (Supplementary Fig. S2). These observations suggest that Spackle–gp5 lysozyme interaction is mediated by mutual conformational changes, likely via an induced-fit mechanism.
Spackle inhibits gp5 lysozyme activity
Based on the results described above, we next tested whether Spackle inhibits lysozyme enzyme activities, using a fluorescence-based assay to monitor the degradation of fluorescein-labeled Micrococcus lysodeikticus cell walls over time. In a titration experiment, adding Spackle at various molar ratios to gp5 lysozyme at a fixed concentration caused a dose-dependent inhibition of the lysozyme activity (Fig. 5a), with weak residual activity observed at equimolar ratio and completely no activity at twofold excess of Spackle. On the other hand, in parallel experiments, Spackle also affected the activity of cytoplasmic T4 lysozyme (hereinafter referred to as endolysin), which shares a 43% sequence identity with the lysozyme domain of gp523 (Figs. 5b and 6). However, the addition of Spackle did not alter the rate of product accumulation by endolysin and instead led to a longer initial lag phase, the reason for which is unknown. In any case, the inhibition of endolysin by Spackle was weak, if any, where we still observed enzyme activity even at fourfold excess of Spackle over endolysin (Fig. 5b). Consistently, we did not detect a stable complex formation between endolysin and Spackle by SEC (Supplementary Fig. S3) as we did for gp5 lysozyme and Spackle (Fig. 1). Lastly, we observed no inhibitory effect of Spackle on hen egg-white lysozyme, which shares the same enzymatic activity but no appreciable sequence homology with either T4 lysozyme (Supplementary Fig. S4). Collectively, these results show that Spackle is a selective inhibitor of gp5 lysozyme.
We found in this study that T4 Spackle forms a stoichiometric complex with the tail spike (gp5) lysozyme and inhibits its enzymatic activity. T4 spackle gene was first identified for the phenotype of its mutation to permit the lysis of bacteria in the absence of T4 endolysin due to a defect in the resistance to “lysis from without”13, which is a mechanism of cell lysis mediated by the adsorption of many phage particles24. Mutations in spackle cause truncation of the latency period known as “lysis-inhibition collapse”25 and a partial loss of superinfection exclusion9,11, consistent with the role of Spackle in inhibiting cell lysis. The original S12 mutation in spackle leads to the replacement of nine amino acid residues from the C-terminus of Spackle with an unrelated sequence13,15,18,25. These residues correspond to α5 helix and the following C-terminal tail, which are shown here to make extensive interaction with gp5 lysozyme (Figs. 2 and 3). Notably, a temperature-sensitive pseudo-revertant of an amber mutation in gene e was isolated and the reversion mutation was mapped in gene 5 (5ts1), which leads to a Gly322 to Asp amino acid substitution in gp5 lysozyme16,26. Our structural data provide a ready explanation (Supplementary Fig. S5)—the G322D substitution would compromise the interaction of gp5 with Spackle by causing a steric clash and therefore let its lysozyme activity complement the loss of gpe/endolysin. Thus, our results rationalize the earlier genetic studies and further support the hypothesis that Spackle functions in the periplasm of T4 phage-infected E. coli cells to inhibit the activity of phage tail lysozyme. An alignment of a total of 178 Spackle homologs from various bacteriophages available in the UniProt database shows generally high sequence conservation, and especially for the residues involved in direct contact with gp5 lysozyme, suggesting a conserved mode of function for these proteins (Supplementary Fig. S6).
Interestingly, while Spackle potently inhibits gp5 lysozyme, it binds to a region distal to the active site and does not directly engage the catalytic residues. Our crystal structures suggest that the inhibition by Spackle is mediated by an allosteric rearrangement of the lysozyme active site and a partial blockage of its oligosaccharide-binding cleft. It is notable that the same side of the oligosaccharide-binding cleft is blocked by the β-helix domain in the full-length trimeric gp5–gp27 complex22 (Supplementary Fig. S1). This mechanism is in contrast to the mode of lysozyme inhibition by other known proteinaceous lysozyme inhibitors, including bacterial Ivy, MliC, PliC, PliG, and PliI, which consist primarily of β-sheet and insert a loop between antiparallel β-strands into the active site to directly engage the lysozyme catalytic residues27,28,29,30,31,32 (Supplementary Fig. S7). The distinct α-helical bundle structure and unique inhibition mechanism of Spackle suggest that it is evolutionarily independent of the bacterial lysozyme inhibitor proteins.
We observed that the cytoplasmic T4 lysozyme, endolysin, is not inhibited by Spackle, despite its high similarity to gp5 lysozyme (Fig. 5). As mentioned above, T4 gp5 lysozyme and endolysin are highly homologous to each other and share a 43% amino acid sequence identity. Thus, it is not surprising that many of the residues involved in the interaction with Spackle are conserved. However, several key basic residues of gp5 are not conserved; Arg182, Arg312, and Lys321 of gp5 align with non-polar residues Ile9, Ala134, and Pro143 of endolysin (Fig. 6). In addition, the main-chain amide group of Lys321 and Gly322 of gp5 are involved in hydrogen-bonding with Spackle (Fig. 3), where the corresponding endolysin residues Pro143 and Asn144 are not compatible with the same interaction due to the lack of amide hydrogen and clash of the Asn side chain (analogous to gp5 G322D mentioned above), respectively. These differences are likely to hamper optimal interaction between Spackle and T4 endolysin, consistent with the lack of stable complex formation in our binding experiment by SEC (Supplementary Fig. S3) and leading to the weaker if any, inhibition. Given also that endolysin is one of the T4 late gene products that function at the last stage of the phage lytic cycle33, it seems unlikely that Spackle, one of the early gene products, would physiologically interact with endolysin.
T4 Spackle, gp5 tail lysozyme, and T4 endolysin (gpe lysozyme) were recombinantly expressed in E. coli strain BL21(DE3) with a C-terminal 6×His-tag from pET-24a-based expression vectors and purified using nickel-affinity and SEC. In all cases the lysis of E. coli was carried out only by sonication and no lysozyme was added. The purified proteins in storage buffer containing 20 mM Tris-HCl pH 7.4, 0.5 M NaCl, and 5 mM β-mercaptoethanol (only for T4 endolysin, as Spackle and gp5 lysozyme have no free Cys), were flash-frozen in liquid nitrogen and stored at −80 °C.
Protein crystallization and structure determination
Purified Spackle and gp5 lysozyme were mixed in a 1:1 molar ratio to yield a complex of ~0.6 mM (~18 mg ml−1). The Spackle–gp5 lysozyme crystals were grown by the hanging-drop vapor diffusion method by mixing the complex solution with an equal volume of a reservoir solution consisting of 35% (w/v) polyethylene glycol 3350, 20% 2-propanol, 0.1 M HEPES–NaOH pH 7.5. The crystals, which were long but thin rod-shaped, were directly flash-cooled by plunging into liquid nitrogen. X-ray diffraction data were collected at the Northeastern Collaborative Access Team (NE-CAT) beamlines of the Advanced Photon Source (APS, Lemont, IL) and processed using XDS34. The structure of the Spackle–gp5 lysozyme complex was determined by molecular replacement phasing by PHASER35, using the crystal structures of free Spackle (PDB ID: 6X6O) and gp5 lysozyme (PDB ID: 1WTH)22 as the search models. Iterative model building and refinement were performed using Coot36 and PHENIX37, respectively. A summary of data collection and model refinement statistics is shown in Table 1. Ramachandran plot shows favorable backbone geometries with 98.5% and 1.5% in the favored and allowed regions, respectively, for the monoclinic crystal form (6XC0), and 97.9 and 2.1% for the orthorhombic (6XC1) crystal form.
Protein–protein binding studies
A 500 μL sample containing approximately 0.2 mM of either Spackle or gp5 lysozyme, or an equimolar mixture of both proteins, was injected into Superdex 75 10/300 SEC column. The column was operated at 4 °C with a flow rate of 0.4 ml min−1, and the elution buffer contained 20 mM Tris-HCl pH 7.4 and 0.5 M NaCl. Protein complex formation was assessed by monitoring the elution profiles and analyzing the collected fractions by SDS-PAGE. The SEC column was calibrated using gel filtration standard (Bio-Rad) including thyroglobulin (670 kDa), γ-globulin (158 kDa), ovalbumin (44 kDa), myoglobin (17 kDa), and vitamin B12 (1.35 kDa). The interaction between T4 cytoplasmic (e) lysozyme and Spackle was tested in the same fashion. Uncropped gel images for data shown in Fig. 1 and Supplementary Fig. S3 are provided in Supplementary Fig. S8.
Lysozyme activity assay
The EnzCheck® Lysozyme Assay kit (Molecular Probes) was utilized to measure lysozyme activity in solution. The substrate was comprised of Micrococcus lysodeikticus cell walls, labeled with fluorescein to a degree that fluorescence is quenched. Lysozymes cleave β-(1,4) glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine moieties in peptidoglycan and relieve the quenching, yielding fluorescence proportional to lysozyme activity. A 50 μg mL−1 working suspension of the lysozyme substrate was prepared with a reaction buffer (0.1 M sodium phosphate pH 7.5, 0.1 M NaCl, 2 mM sodium azide). Reactions were performed in 96 chimney-well, flat bottomed black microplates with a final volume of 100 µL. Spackle protein was serially diluted across six wells with storage buffer achieving final concentrations of 104 µM, 52, 26, 13, 6.5, and 0 µM. Each lysozyme was added to 26 µM. To compensate for lower protein concentrations in some wells and the controls, 15 µM (1 mg mL−1, final concentration) of bovine serum albumin (BSA) was added to all wells. All proteins were mixed first in 50 µL storage buffer and incubated at room temperature for 15 min. A volumetric equivalent of 50 µg mL−1 lysozyme substrate, prepared as described above, was then added to each well before manually transferring the plate to the plate reader and immediately beginning fluorescence scan. Control samples contained Spackle (104 µM), BSA, and the substrate, but no lysozymes. Another set of control samples containing only BSA and the substrate was utilized to establish baseline fluorescence. Fluorescence intensity was measured using a Tecan Spark 10M microplate reader under a standard fluorescein setting: excitation/emission wavelengths of 494/521 nm. Wells were incubated at 35 °C and scanned every 30 s to monitor the kinetics of lysozyme activity. All samples including the controls were quadruplicated. Following scans, the average fluorescence of the BSA and substrate only samples was determined to be the baseline fluorescence and was subtracted from all experimental samples. The results were plotted as the average ± standard deviation.
Statistics and reproducibility
The source data underlying Fig. 5 and Supplementary Fig. S4 are provided as supplementary data in the Excel spreadsheets. All samples were quadruplicated and the graphs show the average ± standard deviation for each data point.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The coordinates and structure factors for the crystal structures reported in this paper have been deposited in the Protein Data Bank with accession codes 6XC0 and 6XC1.
Nobrega, F. L. et al. Targeting mechanisms of tailed bacteriophages. Nat. Rev. Microbiol. 16, 760–773 (2018).
Washizaki, A., Yonesaki, T. & Otsuka, Y. Characterization of the interactions between Escherichia coli receptors, LPS and OmpC, and bacteriophage T4 long tail fibers. Microbiologyopen 5, 1003–1015 (2016).
Leiman, P. G. et al. Morphogenesis of the T4 tail and tail fibers. Virol. J. 7, 355 (2010).
Taylor, N. M. et al. Structure of the T4 baseplate and its function in triggering sheath contraction. Nature 533, 346–352 (2016).
Kanamaru, S. et al. Structure of the cell-puncturing device of bacteriophage T4. Nature 415, 553–557 (2002).
Nakagawa, H., Arisaka, F. & Ishii, S. Isolation and characterization of the bacteriophage T4 tail-associated lysozyme. J. Virol. 54, 460–466 (1985).
Kanamaru, S., Gassner, N. C., Ye, N., Takeda, S. & Arisaka, F. The C-terminal fragment of the precursor tail lysozyme of bacteriophage T4 stays as a structural component of the baseplate after cleavage. J. Bacteriol. 181, 2739–2744 (1999).
Hu, B., Margolin, W., Molineux, I. J. & Liu, J. Structural remodeling of bacteriophage T4 and host membranes during infection initiation. Proc. Natl Acad. Sci. USA 112, E4919–E4928 (2015).
Cornett, J. B. Spackle and immunity functions of bacteriophage T4. J. Virol. 13, 312–321 (1974).
Labrie, S. J., Samson, J. E. & Moineau, S. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 8, 317–327 (2010).
Lu, M. J. & Henning, U. Superinfection exclusion by T-even-type coliphages. Trends Microbiol. 2, 137–139 (1994).
Obringer, J. W. The functions of the phage T4 immunity and spackle genes in genetic exclusion. Genet. Res. 52, 81–90 (1988).
Emrich, J. Lysis of T4-infected bacteria in the absence of lysozyme. Virology 35, 158–165 (1968).
Emrich, J. & Streisinger, G. The role of phage lysozyme in the life cycle of phage T4. Virology 36, 387–391 (1968).
Kai, T., Ueno, H., Otsuka, Y., Morimoto, W. & Yonesaki, T. Gene 61.3 of bacteriophage T4 is the spackle gene. Virology 260, 254–259 (1999).
Kao, S. H. & McClain, W. H. Roles of bacteriophage T4 gene 5 and gene s products in cell lysis. J. Virol. 34, 104–107 (1980).
Kao, S. H. & McClain, W. H. Baseplate protein of bacteriophage T4 with both structural and lytic functions. J. Virol. 34, 95–103 (1980).
Abedon, S. T. Look who’s talking: t-even phage lysis inhibition, the granddaddy of virus-virus intercellular communication research. Viruses 11, 951 (2019).
Shi, K., Kurniawan, F., Banerjee, S., Moeller, N. H. & Aihara, H. Crystal structure of bacteriophage T4 Spackle as determined by native SAD phasing. Acta Cryst. D76, 899–904 (2020).
Anderson, W. F., Grutter, M. G., Remington, S. J., Weaver, L. H. & Matthews, B. W. Crystallographic determination of the mode of binding of oligosaccharides to T4 bacteriophage lysozyme: implications for the mechanism of catalysis. J. Mol. Biol. 147, 523–543 (1981).
Kuroki, R., Weaver, L. H. & Matthews, B. W. A covalent enzyme-substrate intermediate with saccharide distortion in a mutant T4 lysozyme. Science 262, 2030–2033 (1993).
Kanamaru, S., Ishiwata, Y., Suzuki, T., Rossmann, M. G. & Arisaka, F. Control of bacteriophage T4 tail lysozyme activity during the infection process. J. Mol. Biol. 346, 1013–1020 (2005).
Mosig, G., Lin, G. W., Franklin, J. & Fan, W. H. Functional relationships and structural determinants of two bacteriophage T4 lysozymes: a soluble (gene e) and a baseplate-associated (gene 5) protein. New Biol. 1, 171–179 (1989).
Abedon, S. T. Lysis from without. Bacteriophage 1, 46–49 (2011).
Abedon, S. T. Bacteriophage T4 resistance to lysis-inhibition collapse. Genet. Res. 74, 1–11 (1999).
Takeda, S., Hoshida, K. & Arisaka, F. Mapping of functional sites on the primary structure of the tail lysozyme of bacteriophage T4 by mutational analysis. Biochim. Biophys. Acta 1384, 243–252 (1998).
Abergel, C. et al. Structure and evolution of the Ivy protein family, unexpected lysozyme inhibitors in Gram-negative bacteria. Proc. Natl Acad. Sci. USA 104, 6394–6399 (2007).
Callewaert, L. et al. Guards of the great wall: bacterial lysozyme inhibitors. Trends Microbiol. 20, 501–510 (2012).
Leysen, S. et al. The structure of the proteinaceous inhibitor PliI from Aeromonas hydrophila in complex with its target lysozyme. Acta Crystallogr. D Biol. Crystallogr. 71, 344–351 (2015).
Leysen, S., Vanderkelen, L., Weeks, S. D., Michiels, C. W. & Strelkov, S. V. Structural basis of bacterial defense against g-type lysozyme-based innate immunity. Cell Mol. Life Sci. 70, 1113–1122 (2013).
Um, S. H. et al. Structural basis for the inhibition of human lysozyme by PliC from Brucella abortus. Biochemistry 52, 9385–9393 (2013).
Yum, S. et al. Structural basis for the recognition of lysozyme by MliC, a periplasmic lysozyme inhibitor in Gram-negative bacteria. Biochem. Biophys. Res. Commun. 378, 244–248 (2009).
McPheeters, D. S., Christensen, A., Young, E. T., Stormo, G. & Gold, L. Translational regulation of expression of the bacteriophage T4 lysozyme gene. Nucleic Acids Res. 14, 5813–5826 (1986).
Kabsch, W. Xds. Acta Crystallogr. D Biol. Crystallogr. 66, 125–132 (2010).
McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010).
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861–877 (2019).
Robert, X. & Gouet, P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42, W320–W324 (2014).
This work was supported by a grant from the US National Institutes of Health (NIGMS R35-GM118047 to H.A.). This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the US National Institutes of Health (NIGMS P30 GM124165). The Pilatus 6M detector on 24-ID-C beamline is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357, and those of the Minnesota Supercomputing Institute.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shi, K., Oakland, J.T., Kurniawan, F. et al. Structural basis of superinfection exclusion by bacteriophage T4 Spackle. Commun Biol 3, 691 (2020). https://doi.org/10.1038/s42003-020-01412-3